Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 2, 2018Progress in Retinal and Eye ResearchOpen Access

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

HMHemal MehtaThe University of SydneyATAdnan TufailMoorfields Eye Hospital NHS Foundation TrustVDVincent DaïenThe University of Sydney

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mehta et al. (2018) studied this question.

synapsesocial.com/papers/6a945e50d05beabec064ce22https://doi.org/10.1016/j.preteyeres.2017.12.002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration2017 · 129 citations
  2. 2Missing.... presumed at random: cost‐analysis of incomplete data2002 · 349 citations
  3. 3Machine Learning to Analyze the Prognostic Value of Current Imaging Biomarkers in Neovascular Age-Related Macular Degeneration2017 · 197 citations
  4. 4Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research2014 · 83 citations
  5. 5Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images2017 · 672 citations